Levi & Korsinsky is investigating the Board of Directors of Home Diagnostics, Inc. (“Home Diagnostics” or the “Company”) (NasdaqGS: HDIX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Nipro Corp. Under the terms of the transaction, Home Diagnostics shareholders will receive $11.50 per share in cash for each share of Home Diagnostics they own for a total transaction value is approximately $215 million. The investigation concerns whether the Home Diagnostics Board of Directors breached their fiduciary duties to Home Diagnostics stockholders by failing to adequately shop the Company before entering into this transaction and whether Nipro Corp. is underpaying for Home Diagnostics shares, thus unlawfully harming Home Diagnostics stockholders. If you are a current holder of Home Diagnostics and would like additional information, please contact us at the number listed below or visit http://www.zlk.com/hdix1.html. Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.